Epidemiological marker of Hepatitis – B is
**Question:** Epidemiological marker of Hepatitis – B is
A. Hepatitis B surface antigen (HBsAg)
B. Hepatitis B e antigen (HBeAg)
C. Hepatitis B virus (HBV) DNA
D. Hepatitis B core antibody (anti-HBc)
**Correct Answer:** A. Hepatitis B surface antigen (HBsAg)
**Core Concept:** Hepatitis B is a viral infection caused by the Hepatitis B virus (HBV) that affects the liver. The disease can lead to chronic hepatitis, liver cirrhosis, and liver cancer if not treated or managed properly. Hepatitis B is typically transmitted through contact with infected blood or body fluids.
**Why the Correct Answer is Right:** Hepatitis B surface antigen (HBsAg) is a protein produced by the HBV during the acute stage of infection. It is detected in the blood of infected individuals and serves as an essential marker for the diagnosis of acute and chronic Hepatitis B infection. By testing for HBsAg, healthcare professionals can identify and isolate infected individuals, preventing the spread of the virus to others.
**Why Each Wrong Option is Incorrect:**
**A. Hepatitis B surface antigen (HBsAg):** As mentioned earlier, HBsAg is produced during the acute stage of infection and is essential for diagnosing acute and chronic Hepatitis B. However, it is not an epidemiological marker.
**B. Hepatitis B e antigen (HBeAg):** Hepatitis B e antigen is produced during the acute stage of infection and is a marker for active viral replication. While it can provide information about the severity of the infection, it is not considered an epidemiological marker.
**C. Hepatitis B virus (HBV) DNA:** Hepatitis B virus DNA is the genetic material of the virus. Testing for HBV DNA is essential for assessing viral load, monitoring treatment response, and detecting the presence of the virus. However, it is not a direct epidemiological marker.
**D. Hepatitis B core antibody (anti-HBc):** Hepatitis B core antibody is produced during the recovery phase of infection and indicates past exposure to HBV. Although it can provide information about the immune response, it is not considered an epidemiological marker.
**Clinical Pearl:** Epidemiological markers for Hepatitis B include Hepatitis B surface antibody (anti-HBs), which indicates immunity to the virus after vaccination or recovery from the infection.
**Explanation of each wrong option:**
**Option A (HBsAg):** Hepatitis B surface antigen is a marker for the active replication of the virus and indicates acute infection. It is not an epidemiological marker.
**Option B (HBeAg):** Hepatitis B e antigen is a marker of active viral replication and severe liver inflammation. It is not an epidemiological marker.
**Option C (HBV DNA):** Hepatitis B virus DNA is the genetic material of the virus. Testing for HBV DNA is important for assessing viral load, monitoring treatment response, and detecting the presence of the virus. However, it